Cleared Traditional

K921686 - ENDOMED LAPAROSCOPY INSTRUMENTS (FDA 510(k) Clearance)

Class II Obstetrics & Gynecology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K921686 · Buckman Co., Inc. · Obstetrics & Gynecology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 1994
Decision
721d
Days
Class 2
Risk

K921686 is an FDA 510(k) clearance for the ENDOMED LAPAROSCOPY INSTRUMENTS. Classified as Coagulator-cutter, Endoscopic, Unipolar (and Accessories) (product code KNF), Class II - Special Controls.

Submitted by Buckman Co., Inc. (Concord, US). The FDA issued a Cleared decision on March 30, 1994 after a review of 721 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Obstetrics & Gynecology FDA review panel, regulated under 21 CFR 884.4160 - the FDA obstetrics and gynecology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Obstetrics & Gynecology submissions.

View all Buckman Co., Inc. devices

Submission Details

510(k) Number K921686 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 08, 1992
Decision Date March 30, 1994
Days to Decision 721 days
Submission Type Traditional
Review Panel Obstetrics & Gynecology (OB)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
561d slower than avg
Panel avg: 160d · This submission: 721d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code KNF Coagulator-cutter, Endoscopic, Unipolar (and Accessories)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 884.4160
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Obstetrics & Gynecology devices follow this clearance model.

Regulatory Peers - KNF Coagulator-cutter, Endoscopic, Unipolar (and Accessories)

All 43
Devices cleared under the same product code (KNF) and FDA review panel - the closest regulatory comparables to K921686.
Sonata Transcervical Fibroid Ablation System 2.2
K250705 · Gynesonics, Inc. · Apr 2025
Sonata Transcervical Fibroid Ablation System 2.2
K240503 · Gynesonics, Inc. · Jul 2024
Sonata Transcervical Fibroid Ablation System 2.2 (SONATA2-220)
K233848 · Gynesonics, Inc. · Dec 2023
Sonata Transcervical Fibroid Ablation System 2.2
K222304 · Gynesonics, Inc. · Nov 2022